Evgeny (Eugene) Izumchenko is an Assistant Professor of Medicine in the Department of Medicine, Section of Hematology/Oncology, University of Chicago. Eugene is a leading researcher in the field of Notch signaling and carcinogenesis, and has an extensive background in tumor biology, molecular oncology, immunogenetics and genomics technologies.
Eugene’s research focus is on understanding the complex interplay between the genetic and epigenetic alterations in carcinogenesis and disease progression, and on exploiting this understanding for developing novel biomarkers for diagnosis and risk stratification as well as in identifying targets for therapeutic intervention. He has multiple publications, including in Nature Communications, Cancer Research, Clinical Cancer Research, Annals of Oncology and Cancer Discoveries.
Eugene received his PhD from Ben-Gurion University via the BGU /Fox Chase Cancer Center (FCCC) Partnership Graduate Research Program, where he provided some of the earliest insights on biomarkers for early assessment of breast tumor aggressiveness, and completed his postdoctoral training at the University of Florida, where he described novel mechanism by which dysregulation of genomic stability drives cancer development.